Study of the Adequacy Between Calcium Supplementation and Dietary Intake in Treatment-naive Patients After a Fracture
MONTE-CRIST'OS
2 other identifiers
observational
100
1 country
1
Brief Summary
Osteoporosis is a disease that causes many fractures. However, treatments exist such as anti-osteoporotic treatments, vitamin D supplementation and an adaptation of calcium intake. 80% of patients with an indication for anti-osteoporotic treatment are never treated with these anti-osteoporotic treatments after a first fracture. On the other hand, more than 84% of them are supplemented with calcium and vitamin D. It often appears in the practice of rheumatologists that some patients are supplemented while their dietary intake is sufficient, and vice versa. The objective of the study is therefore to take stock of the (in)adequacy between the dietary intake of patients and the supplementation prescribed to them following an osteoporotic-like fracture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2025
CompletedFirst Posted
Study publicly available on registry
February 26, 2025
CompletedStudy Start
First participant enrolled
April 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 16, 2025
July 1, 2025
10 months
February 21, 2025
July 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients deficient, within the norm and above the norm with or without supplementation
percentage of patients
Day 1
Secondary Outcomes (5)
Previously performed bone densitometry
Day 1
Prevalence of a history of fracture
Day 1
First indication for the initiation of anti-osteoporotic treatment.
Day 1
Duration without treatment before a fracture occurs
Day 1
Number of participants who need for readjustment by the rheumatologist after inclusion
Day 1
Interventions
Assessment of the inadequacy between dietary and medicinal calcium intake by the Fardellone self-questionnaire and the patient's clinical record
Eligibility Criteria
Patients consulting in a rheumatology department for a hospital
You may qualify if:
- Patient meeting a first rheumatologist after a fracture suspected of being due to bone insufficiency, whether or not he is already treated for osteoporosis
- Age ≥ 18 years
- Patient followed in one of the three investigation centers within the framework of the bone sector.
- Patient affiliated to a social security system
You may not qualify if:
- Patient refusing to participate in the study
- Patient already followed by a rheumatologist
- Legal incapacity or any physical, psychological, social or geographical condition likely to hinder the patient's ability to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpitaux Civils de Colmar
Colmar, 68024, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2025
First Posted
February 26, 2025
Study Start
April 3, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
July 16, 2025
Record last verified: 2025-07